AH

Alife Health

IVF powered by artificial intelligence

San Francisco, United States · Founded 2020 · $22.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$22.0M
Last Round
$22.0M Series AMar 2022
Rounds
1

About

Alife Health is an AI-powered fertility technology company modernizing the IVF process with cutting-edge clinical tools designed to improve outcomes and reduce costs. Its flagship product, Embryo Predict — FDA-cleared in 2026 — provides labs with consistent, objective AI embryo scoring to aid in every transfer decision. The platform also includes Schedule Predict, which reduces over-capacity retrieval days by up to 65%, and Success Predictor, which increases patient conversion by more than 3%. Alife's technology is trusted by leading fertility networks including US Fertility, Inception Fertility, Shady Grove Fertility, and RSC Bay Area.

Summary

Alife Health is an Artificial Intelligence company based in San Francisco, United States, founded in 2020. It has raised $22.0M in total across 1 round, most recently a $22.0M Series A round in Mar 2022.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AMar 2022
$22.0M

Similar Companies